Abstract
Molecular genetics is a rapidly expanding field with possibilities for novel diagnostic and treatment strategies for otological diseases. Gene therapy, if theory is proven practical, could eliminate disease at the molecular level, thus obviating the need for pharmacologic or surgical treatment. Recent years have seen great advances in our understanding of the molecular genetic basis of many otological disorders. Building on the success of the Human Genome Project, new technologies are in development to identify disease-causing mutations through genetic testing. A basic understanding of the genetic basis of Otological diseases is crucial to the practising Otologist and the time has come for genetic services to be incorporated into regular Otological clinics.
Similar content being viewed by others
References
Morton CC, Nance WE (2006) Newborn hearing screening: a silent revolution. N Engl J Med 354:2151–2164
Smith RJ, BaleJ F Jr, White KR (2005) Sensorineural hearing loss in children. Lancet 365:879–890
Marres HA (1988) Congenital abnormalities of the inner ear. In: Ludman H, Bath WT (eds) Diseases of the ear. Arnold & Oxford University Press, Oxford, pp 288–296
Friedman TB, Griffith AJ (2003) Human nonsyndromic sensorineural deafness. Annu Rev Genomics Hum Genet 4:341–402
Kochhar A, Hildebrand MS, Smith RJ (2007) Clinical aspects of hereditary hearing loss. Genet Med 9:393–408
Van Camp G, Willems PJ, Smith RJ (1997) Nonsyndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet 60:758–764
ACMG (2002) Genetics evaluation guidelines for the etiologic diagnosis of congenital hearing loss. Genetic Evaluation of Congenital Hearing Loss Expert Panel: ACMG statement. Genet Med 4:162–171
Hone SW, Smith RJ (2002) Medical evaluation of pediatric hearing loss: laboratory, radiographic, and genetic testing. Otolaryngol Clin North Am 35:751–764
Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu WQ, Arnos KS, Cortopassi GA, Jaber L, Rotter JI, Shohat M, Fischel-Ghodsian N (1993) Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 4:289–294
Kelsell DP, Dunlop J, Stevens HP, Lench NJ, Liang JN, Parry G et al (1997) Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 6628:80–83
Denoyelle F, Weil D, Maw MA, Wilcox SA, Lench NJ, Allen-Powell DR et al (1997) Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet 6:2173–2177
Martin PE, Coleman SL, Casalotti SO, Forge A, Evans WH (1999) Properties of connexin26 gap junctional proteins derived from mutations associated with non-syndromal hereditary deafness. Hum Mol Genet 8:2369–2376
Gasparini P, Rabionet R, Barbujani G, Melchionda S, Petersen M, Brondum-Nielsen K et al (2000) High carrier frequency of the 35delG deafness mutation in European populations. Eur J Hum Genet 8:19–23
Ahmad S, Chen S, Sun J, Lin X (2003) Connexins 26 and 30 are co-assembled to form gap junctions in the cochlea of mice. Biochem Biophys Res Commun 307:362–368
Petit C, Levilliers J, Marlin S, Hardelin J-P (2001) Hereditary hearing loss. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) McGraw-Hill, New York, pp 6281–6328
Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED (1997) Pendred syndrome is caused by mutations in a putative sulphate transporter gene(PDS). Nat Genet 17:411–422
Pryor SP, Madeo AC, Reynolds JC, Sarlis NJ, Arnos KS, Nance WE, Yang Y, Zalewski CK, Brewer CC, Butman JA, Griffith AJ (2005) SLC26A4/PDS genotype-phenotype correlation in hearing loss with enlargement of the vestibular aqueduct (EVA): evidence that Pendred syndrome and non-syndromic EVA are distinct clinical and genetic entities. J Med Genet 42:159–165
Matsunaga T, Kumanomido H, Shiroma M, Goto Y, Usami S (2005) Audiological features and mitochondrial DNA sequence in a large family carrying mitochondrial A1555G mutation without use of aminoglycoside. Ann Otol Rhinol Laryngol 114:153–160
Chinnery PF, Elliott C, Green GR, Rees A, Coulthard A, Turnbull DM, Griffiths TD (2000) The spectrum of hearing loss due to mitochondrial DNA defects. Brain 123(Pt 1):82–92
Brownstein Z, Friedman LM, Shahin H, Oron-Karni V, Kol N, Abu Rayyan A et al (2011) Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome Biol 12:R89
Shearer AE, DeLuca AP, Hildebrand MS, Taylor KR, Gurrola J 2nd, Scherer S et al (2010) Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci USA 107:21104–21109
Walsh T, Shahin H, Elkan-Miller T, Lee MK, Thornton AM, Roeb W et al (2010) Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM21 as the cause of nonsyndromic hearing loss DFNB82. Am J Hum Genet 87:90–94
Usami S, Abe S, Kasai M, Shinkawa H, Moeller B, Kenyon JB, Kimberling WJ (1997) Genetic and clinical features of sensorineural hearing loss associated with the 1555 mitochondrial mutation. Laryngoscope 107:483–490
Rehm HL (2013) Disease-targeted sequencing: a cornerstone in the clinic. Nat Rev Genet 14:295–300
Gubler MC (2007) Diagnosis of Alport syndrome without biopsy? Pediatr Nephrol 22:621–625
Yasunaga S, Grati M, Cohen-Salmon M, El-Amraoui A, Mustapha M, Salem N, El-Zir E, Loiselet J, Petit C (1999) A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nat Genet 21:363–369
Rouillon I, Marcolla A, Roux I, Marlin S, Feldmann D, Couderc R, Jonard L, Petit C, Denoyelle F, Garabédian EN, Loundon N (2006) Results of cochlear implantation in two children with mutations in the OTOF gene. Int J Pediatr Otorhinolaryngol 70:689–696
Rodríguez-Ballesteros M, Reynoso R, Olarte M, Villamar M, Morera C, Santarelli R, Arslan E, Medá C, Curet C, Völter C, Sainz-Quevedo M, Castorina P, Ambrosetti U, Berrettini S, Freil K, Tedín S, Smith J, CruzTapia M, Cavallé L, Gelvez N, Primignani P, Gómez-Rosas E, Martín M, Moreno-Pelayo MA, Tamayo M, Moreno-Barral J, Moreno F, del Castillo I (2008) A multicenter study on the prevalence and spectrum of mutations in the otoferlin gene1 (OTOF) in subjects with nonsyndromic hearing impairment and 222 Matsunaga T: genetic testing in otology auditory neuropathy. Hum Mutat 29:823–831
Kenneson A, Van Naarden Braun K, Boyle C (2002) GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: a HUGE review. Genet Med 4:258–274
Cohn ES, Kelley PM (1999) Clinical phenotype and mutations in connexin 26 (DFNB1/GJB2), the most common cause of childhood hearing loss. Am J Med Genet 89:130–136
Vrabec JT (2010) Genetic investigations of Ménière’s disease. Otolaryngol Clin North Am 43(5):1121–1132
Morrison AW, Bailey ME, Morrison GA (2009) Familial Meniere’s disease: clinical and genetic aspects. J Laryngol Otol 123(1):29–37
Rye MS, Blackwell JM, Jamieson SE (2012) Genetic susceptibility to otitis media in childhood. Laryngoscope 122(3):665–675. doi:10.1002/lary.22506
Hoya N, Okamoto Y, Kamiya K, Fujii M, Matsunaga T (2004) A novel animal model of acute cochlear mitochondrial dysfunction. Neuroreport 15:1597–1600
Okamoto Y, Hoya N, Kamiya K, Fujii M, Ogawa K, Matsunaga T (2005) Permanent threshold shift caused by acute cochlear mitochondrial dysfunction is primarily mediated by degeneration of the lateral wall of the cochlea. Audiol Neurootol 10:220–233
Mizutari K, Matsunaga T, Kamiya K, Fujinami Y, Fujii M, Ogawa K (2008) Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction. J Neurosci Res 86:215–222
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kameswaran, M., Sudhamaheswari, S. & Natarajan, K. Genetics: A New Frontier in Otology. Indian J Otolaryngol Head Neck Surg 68, 1–5 (2016). https://doi.org/10.1007/s12070-016-0972-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-016-0972-6